24/7 Market News Snapshot 20 October, 2025 – OneMedNet Corp Class A Common Stock (NASDAQ:ONMD)
DENVER, Colo., 20 October, 2025 (www.247marketnews.com) – (NASDAQ:ONMD) are discussed in this article.
OneMedNet Corp (ONMD) is witnessing a significant rally, with shares currently trading at $2.765, reflecting an impressive increase of approximately 21.27% from the previous close of $2.280. This surge, propelled by a trading volume of 1.02 million shares, underscores a surge of investor interest and has sparked discussions about the potential for a sustained upward trend for the company.
In conjunction with this market momentum, OneMedNet has announced a strategic partnership with mlHealth360, an innovator in healthcare AI and analytics. This collaboration entails a multi-year agreement that will provide mlHealth360 with ongoing access to OneMedNet’s iRWD™ platform, which includes a comprehensive collection of regulatory-grade, de-identified imaging and clinical data crucial for enhancing AI model development and validation. The partnership allows mlHealth360 to leverage a rich repository of over 1,750 healthcare provider sites’ X-Ray and CT images linked to more than 131 million clinical studies across diverse therapeutic areas.
Aaron Green, President and CEO of OneMedNet, expressed enthusiasm for the partnership, emphasizing that it reflects the trust that organizations place in OneMedNet’s capabilities in delivering live Real-World Data to foster healthcare AI innovation. He noted that such high-value collaborations will play a pivotal role in expanding the company’s subscription base and driving future revenue growth.
Kumar Surender Sinwar, CEO of mlHealth360, highlighted that this strategic alliance enhances their access to premium medical imaging data, essential for advancing patient care. Previously successful collaborations with OneMedNet have prompted mlHealth360 to broaden their initiatives into new domains. This partnership marks a significant step in OneMedNet’s commitment to offering high-quality, multimodal Real-World Data, critical for training AI models, ensuring regulatory compliance, and ultimately improving patient outcomes through innovative healthcare solutions.